336 related articles for article (PubMed ID: 27871870)
1. Carcinogenic risk of emerging persistent organic pollutant perfluorooctane sulfonate (PFOS): A proposal of classification.
Arrieta-Cortes R; Farias P; Hoyo-Vadillo C; Kleiche-Dray M
Regul Toxicol Pharmacol; 2017 Feb; 83():66-80. PubMed ID: 27871870
[TBL] [Abstract][Full Text] [Related]
2. Carcinogenic potency of perfluorooctane sulfonate (PFOS) on Syrian hamster embryo (SHE) cells.
Jacquet N; Maire MA; Landkocz Y; Vasseur P
Arch Toxicol; 2012 Feb; 86(2):305-14. PubMed ID: 22057587
[TBL] [Abstract][Full Text] [Related]
3. Environmental contamination, human exposure and body loadings of perfluorooctane sulfonate (PFOS), focusing on Asian countries.
Zhao YG; Wong CK; Wong MH
Chemosphere; 2012 Oct; 89(4):355-68. PubMed ID: 22794940
[TBL] [Abstract][Full Text] [Related]
4. Hydroquinone: an evaluation of the human risks from its carcinogenic and mutagenic properties.
McGregor D
Crit Rev Toxicol; 2007; 37(10):887-914. PubMed ID: 18027166
[TBL] [Abstract][Full Text] [Related]
5. Assessing the human health risks of perfluorooctane sulfonate by in vivo and in vitro studies.
Zeng Z; Song B; Xiao R; Zeng G; Gong J; Chen M; Xu P; Zhang P; Shen M; Yi H
Environ Int; 2019 May; 126():598-610. PubMed ID: 30856447
[TBL] [Abstract][Full Text] [Related]
6. Ecological impact and environmental fate of perfluorooctane sulfonate on the zooplankton community in indoor microcosms.
Sanderson H; Boudreau TM; Mabury SA; Cheong WJ; Solomon KR
Environ Toxicol Chem; 2002 Jul; 21(7):1490-6. PubMed ID: 12109751
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS).
Fuentes S; Vicens P; Colomina MT; Domingo JL
Toxicology; 2007 Dec; 242(1-3):123-9. PubMed ID: 17950980
[TBL] [Abstract][Full Text] [Related]
8. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis.
Cui L; Zhou QF; Liao CY; Fu JJ; Jiang GB
Arch Environ Contam Toxicol; 2009 Feb; 56(2):338-49. PubMed ID: 18661093
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cellular response to perfluorooctane sulfonate in human umbilical vein endothelial cells.
Liao Y; Wang J; Huang QS; Fang C; Kiyama R; Shen H; Dong S
Toxicol In Vitro; 2012 Apr; 26(3):421-8. PubMed ID: 22269386
[TBL] [Abstract][Full Text] [Related]
10. [Identification of human carcinogenic risks in IARC monographs].
Vainio H; Wilbourn JD; Sasco AJ; Partensky C; Gaudin N; Heseltine E; Eragne I
Bull Cancer; 1995; 82(5):339-48. PubMed ID: 7626841
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of ³⁵S-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose.
Bogdanska J; Borg D; Sundström M; Bergström U; Halldin K; Abedi-Valugerdi M; Bergman A; Nelson B; Depierre J; Nobel S
Toxicology; 2011 Jun; 284(1-3):54-62. PubMed ID: 21459123
[TBL] [Abstract][Full Text] [Related]
12. Chronic exposure to perfluorooctane sulfonate induces behavior defects and neurotoxicity through oxidative damages, in vivo and in vitro.
Chen N; Li J; Li D; Yang Y; He D
PLoS One; 2014; 9(11):e113453. PubMed ID: 25412474
[TBL] [Abstract][Full Text] [Related]
13. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism.
Yu WG; Liu W; Jin YH
Environ Toxicol Chem; 2009 May; 28(5):990-6. PubMed ID: 19045937
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of estrogenic activities and mechanism of action of perfluorinated chemicals determined by vitellogenin induction in primary cultured tilapia hepatocytes.
Liu C; Du Y; Zhou B
Aquat Toxicol; 2007 Dec; 85(4):267-77. PubMed ID: 17980923
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological and experimental applications to occupational cancer prevention.
Vainio H; Hemminki K
J UOEH; 1989 Mar; 11 Suppl():323-45. PubMed ID: 2664947
[TBL] [Abstract][Full Text] [Related]
16. Immunotoxicity of perfluorinated compounds: recent developments.
DeWitt JC; Peden-Adams MM; Keller JM; Germolec DR
Toxicol Pathol; 2012; 40(2):300-11. PubMed ID: 22109712
[TBL] [Abstract][Full Text] [Related]
17. Perfluorooctane sulfonate increases the genotoxicity of cyclophosphamide in the micronucleus assay with V79 cells. Further proof of alterations in cell membrane properties caused by PFOS.
Jernbro S; Rocha PS; Keiter S; Skutlarek D; Färber H; Jones PD; Giesy JP; Hollert H; Engwall M
Environ Sci Pollut Res Int; 2007 Mar; 14(2):85-7. PubMed ID: 17455816
[TBL] [Abstract][Full Text] [Related]
18. Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers.
Alexander BH; Olsen GW
Ann Epidemiol; 2007 Jun; 17(6):471-8. PubMed ID: 17448680
[TBL] [Abstract][Full Text] [Related]
19. Effects of perfluorooctane sulfonate on the immune responses and expression of immune-related genes in Chinese mitten-handed crab Eriocheir sinensis.
Zhang F; Wei J; Li Q; Jiang R; Yu N; Qin J; Chen L
Comp Biochem Physiol C Toxicol Pharmacol; 2015; 172-173():13-8. PubMed ID: 25900200
[TBL] [Abstract][Full Text] [Related]
20. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells.
Sonthithai P; Suriyo T; Thiantanawat A; Watcharasit P; Ruchirawat M; Satayavivad J
J Appl Toxicol; 2016 Jun; 36(6):790-801. PubMed ID: 26234195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
